ICON Public (NASDAQ:ICLR) Issues FY 2025 Earnings Guidance

ICON Public (NASDAQ:ICLR) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 13.000-15.000 for the period, compared to the consensus earnings per share estimate of 14.200. The company issued revenue guidance of $8.1 billion-$8.7 billion, compared to the consensus revenue estimate of $8.4 billion.

Wall Street Analyst Weigh In

ICLR has been the topic of a number of research reports. Robert W. Baird reduced their target price on shares of ICON Public from $221.00 to $203.00 and set a “neutral” rating on the stock in a research report on Tuesday. JPMorgan Chase & Co. reduced their price objective on ICON Public from $280.00 to $265.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. Barclays lowered their target price on ICON Public from $275.00 to $240.00 and set an “overweight” rating for the company in a research note on Friday, February 21st. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $263.00 price objective on shares of ICON Public in a research note on Wednesday, January 15th. Finally, William Blair reaffirmed an “outperform” rating on shares of ICON Public in a research note on Tuesday, January 14th. Four analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $279.17.

ICON Public Trading Up 1.6 %

ICLR stock opened at $186.49 on Thursday. ICON Public has a 52 week low of $179.50 and a 52 week high of $347.72. The company has a market capitalization of $15.06 billion, a PE ratio of 19.57, a price-to-earnings-growth ratio of 1.86 and a beta of 1.21. The company’s 50-day simple moving average is $200.78 and its 200 day simple moving average is $238.28. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.34 and a current ratio of 1.26.

ICON Public (NASDAQ:ICLR) last announced its earnings results on Wednesday, February 19th. The medical research company reported $3.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.41 by $0.01. ICON Public had a net margin of 9.56% and a return on equity of 11.81%. The firm had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.04 billion. As a group, sell-side analysts anticipate that ICON Public will post 13.38 earnings per share for the current year.

About ICON Public

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.